Cell-based assays and molecular simulation reveal that the anti-cancer harmine is a specific matrix metalloproteinase-3 (MMP-3) inhibitor (Q113318561)
Appearance
scientific article published on 06 August 2021
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Cell-based assays and molecular simulation reveal that the anti-cancer harmine is a specific matrix metalloproteinase-3 (MMP-3) inhibitor |
scientific article published on 06 August 2021 |
Statements
Cell-based assays and molecular simulation reveal that the anti-cancer harmine is a specific matrix metalloproteinase-3 (MMP-3) inhibitor (English)
Li-Te Chin
Ke-Wei Liu
Yi-Han Chen
Shu-Ching Hsu
Lin Huang
6 August 2021